British Journal of Medical & Surgical Urology
Volume 2, Issue 4 , Pages 171-173, July 2009

Patient designed therapy provides possible “natural” selection evidence for testosterone as differentiating agent for high-grade prostate cancer

  • G.L. Shaw

      Affiliations

    • St Barts & The London Hospitals, London, United Kingdom
    • Corresponding Author InformationCorresponding author at: St Barts & The London Hospitals, London, United Kingdom.
    • ,
  • M.E. Emberton

      Affiliations

    • University College Hospital London, United Kingdom
    • ,
  • R. Morgan

      Affiliations

    • Royal Free Hospital, United Kingdom
    • ,
  • D. Berney

      Affiliations

    • St Barts & The London Hospitals, London, United Kingdom
    • Wolfson Institute and Institute of Cancer, Queen Mary University of London, United Kingdom
    • ,
  • J. Cuzick

      Affiliations

    • Wolfson Institute and Institute of Cancer, Queen Mary University of London, United Kingdom
    • ,
  • R.T.D. Oliver

      Affiliations

    • University College Hospital London, United Kingdom

Received 15 November 2008; accepted 14 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1875-9742(08)00154-7

doi:10.1016/j.bjmsu.2008.12.005

British Journal of Medical & Surgical Urology
Volume 2, Issue 4 , Pages 171-173, July 2009

Article Tools